Biohaven Pharmaceutical Holding[...]
US FDA Accepts for Review Biohaven's New Drug Application (NDA) Filing[...]
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study[...]
10/19/2021 | Press release | Distributed by Public on 10/19/2021 02:12
Please select the service you want to use:
Smartlinks | Intracom Holdings SA | News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Telecommunications Services | Public Companies | Communications and Networking Equipment Manufacturers | Börse Frankfurt | Athens Exchange (ATHEX) | Börse Berlin | Börse Stuttgart | Cboe Off Exchange
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact